Javascript must be enabled to continue!
North Carolina macular dystrophy shows a particular drusen phenotype and atrophy progression
View through CrossRef
Background/AimTo provide a comprehensive multimodal retinal imaging characterisation of patients with North Carolina macular dystrophy (NCMD).MethodsClinical evaluation and retinal imaging in six families.ResultsTwenty-one subjects showed phenotypic characteristics of NCMD . Small drusen-like deposits were found in all affected individuals, either tightly grouped in the macula, or surrounding atrophic or fibrotic macular alterations. These small subretinal lesions showed an increased fundus autofluorescence and were associated with only mild irregularities on optical coherence tomography imaging. Similar drusen-like deposits were regularly seen in the peripheral fundus, predominantly temporally and often with a radial distribution. Two patients showed a bilateral chorioretinal atrophy and two had a macular neovascularisation (MNV). Findings from follow-up examinations were available from 11 patients. The retinal phenotype remained overall stable, except for two patients: one patient with atrophy showed a distinct growth of the atrophic lesions on longitudinal AF imaging over a review period of 14 years. One patient with MNV showed a unilateral decline of best-corrected visual acuity. Genetic testing identified the single nucleotide variant chr6:100040987G>C upstream of thePRDM13gene in all family members with NCMD phenotype.ConclusionPatients with NCMD show a characteristic retinal phenotype and distribution of drusen that differ from drusen in patients with age-related macular degeneration. Although the prognosis of this developmental condition is overall better than for other macular diseases with drusen, patients may be at risk of developing MNV or enlargement of pre-existing atrophy.
Title: North Carolina macular dystrophy shows a particular drusen phenotype and atrophy progression
Description:
Background/AimTo provide a comprehensive multimodal retinal imaging characterisation of patients with North Carolina macular dystrophy (NCMD).
MethodsClinical evaluation and retinal imaging in six families.
ResultsTwenty-one subjects showed phenotypic characteristics of NCMD .
Small drusen-like deposits were found in all affected individuals, either tightly grouped in the macula, or surrounding atrophic or fibrotic macular alterations.
These small subretinal lesions showed an increased fundus autofluorescence and were associated with only mild irregularities on optical coherence tomography imaging.
Similar drusen-like deposits were regularly seen in the peripheral fundus, predominantly temporally and often with a radial distribution.
Two patients showed a bilateral chorioretinal atrophy and two had a macular neovascularisation (MNV).
Findings from follow-up examinations were available from 11 patients.
The retinal phenotype remained overall stable, except for two patients: one patient with atrophy showed a distinct growth of the atrophic lesions on longitudinal AF imaging over a review period of 14 years.
One patient with MNV showed a unilateral decline of best-corrected visual acuity.
Genetic testing identified the single nucleotide variant chr6:100040987G>C upstream of thePRDM13gene in all family members with NCMD phenotype.
ConclusionPatients with NCMD show a characteristic retinal phenotype and distribution of drusen that differ from drusen in patients with age-related macular degeneration.
Although the prognosis of this developmental condition is overall better than for other macular diseases with drusen, patients may be at risk of developing MNV or enlargement of pre-existing atrophy.
Related Results
Analysis of the Relationship Between Drusen Size and Drusen Area in Eyes With Age-Related Macular Degeneration
Analysis of the Relationship Between Drusen Size and Drusen Area in Eyes With Age-Related Macular Degeneration
BACKGROUND AND OBJECTIVE:
To examine the relationship between drusen counts and drusen area in eyes with age-related macular degeneration, and to correlate drusen areas...
Clinical manifestations of cuticular drusen in Korean patients
Clinical manifestations of cuticular drusen in Korean patients
Abstract
Cuticular drusen show some similarities to and differences from soft drusen in age-related macular degeneration (AMD) and might thus be a unique AMD subt...
Morphological changes of macular soft drusen and drusenoid DPED after subthreshold micropulse laser treatment
Morphological changes of macular soft drusen and drusenoid DPED after subthreshold micropulse laser treatment
AIM: To analyze the morphological changes of macular soft drusen and drusenoid pigmental epithelium detachment (DPED) after subthreshold micropulse laser treatment (SMLT).
METHODS:...
Parapapillary drusen of the retinal pigment epithelium
Parapapillary drusen of the retinal pigment epithelium
AbstractPurposeTo describe the occurrence, morphology and associations of parapapillary drusen of the retinal pigment epithelium (RPE‐drusen).MethodsUsing light microscopy, we hist...
ÜBER DRÜSEN‐NERVENZELLEN UND NEUROSEKRETORISCHE ORGANE BEI WIRBELLOSEN UND WIRBELTIEREN
ÜBER DRÜSEN‐NERVENZELLEN UND NEUROSEKRETORISCHE ORGANE BEI WIRBELLOSEN UND WIRBELTIEREN
ZusammenfassungWir stellen hier die “Drüsen‐Nervenzelle” als einen neuen Zelltypus zur Diskussion. Wir verstehen darunter Nervenzellen, die mehr oder weniger das Bild sekretorisch ...
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial
Abstract
Purpose
Determine rates of progression of incomplete retinal pigment epithelium and outer retinal atrophy (iRORA...
PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Purpose:
To evaluate the size and location of macular atrophy in eyes with Type-1 neovascularization (NV) and age-related macular degeneration receiving chronic...
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Abstract
Background
Clinical neuroradiologists routinely look for expansion of CSF spaces to help identify atrophy on patient MRI scans. In contrast, automated methods for...

